In records from over 2 million surgical patients, GLP-1 users had 11% lower odds of major cardiac events and 8% lower odds of infections. The study can't say whether pausing the drug matters.
Recap by typeshit. Full story at Inside Precision Medicine.
A Facebook post says US researchers found pancreatic cells producing GLP-1 on their own. It frames this as a possible built-in appetite and sugar control system, without naming the study.
Researchers are studying whether GLP-1 drugs, which act on mood, appetite and reward pathways, could help with depression, addiction and binge eating.
A retrospective cohort checks whether retinal disease started or worsened more in established users than in people never on either drug, plus a regional NAION review.
24:34
An animated explainer walking through what semaglutide does in the body, from appetite signals in the brain to digestion and blood sugar control.
A personal story about the control he felt on the drug and the cravings for it that followed once he stopped.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Loading…